Cue biopharma to present at the 2021 federation of clinical immunology societies (focis) virtual annual meeting

Cambridge, mass., june 03, 2021 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted t cells directly within the patient's body, announced today it will give a presentation at the 2021 federation of clinical immunology societies (focis) annual meeting, which is being held virtually from june 8-11, 2021.
CUE Ratings Summary
CUE Quant Ranking